United States - English - NLM (National Library of Medicine)

strides pharma science limited - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - accolate is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older. accolate is contraindicated in patients who are hypersensitive to zafirlukast or any of its inactive ingredients. accolate is contraindicated in patients with hepatic impairment including hepatic cirrhosis.

United States - English - NLM (National Library of Medicine)

par pharmaceutical inc. - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast 10 mg

United States - English - NLM (National Library of Medicine)

astrazeneca pharmaceuticals lp - zafirlukast (unii: xz629s5l50) (zafirlukast - unii:xz629s5l50) - zafirlukast 10 mg

Ireland - English - HPRA (Health Products Regulatory Authority)

astrazeneca uk limited - zafirlukast - coated tablets - 20 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

astrazeneca uk limited - zafirlukast - coated tablets - 40 milligram

Ireland - English - HPRA (Health Products Regulatory Authority)

pco manufacturing - zafirlukast - film coated tablet - 20 milligram - leukotriene receptor antagonists

Bangladesh - English - DGDA (Directorate General of Drug Administration)

alco pharma limited - zafirlukast - tablet - 20 mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

beximco pharmaceuticals ltd. - zafirlukast - tablet - 20 mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

eskayef pharmaceuticals ltd. mirpur. - zafirlukast - tablet - 20 mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

general pharmaceuticals ltd. - zafirlukast - tablet - 20 mg